Glycogen Synthase Kinase-3 as a Therapeutic Target for Cognitive Dysfunction in Neuropsychiatric Disorders
出版年份 2014 全文链接
标题
Glycogen Synthase Kinase-3 as a Therapeutic Target for Cognitive Dysfunction in Neuropsychiatric Disorders
作者
关键词
Morris Water Maze, Hippocampal Neurogenesis, Lithium Treatment, Adult Hippocampal Neurogenesis, Spatial Memory Deficit
出版物
CNS DRUGS
Volume 29, Issue 1, Pages 1-15
出版商
Springer Nature
发表日期
2014-11-15
DOI
10.1007/s40263-014-0213-z
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Faster, better, stronger: Towards new antidepressant therapeutic strategies
- (2015) Olivia F. O’Leary et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Alzheimer's disease, enzyme targets and drug discovery struggles: From natural products to drug prototypes
- (2014) Tiago Silva et al. AGEING RESEARCH REVIEWS
- Glycogen synthase kinase 3 beta gene structural variants as possible risk factors of bipolar depression
- (2014) Zsolt Ronai et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Neuroprotective role of Indirubin-3′-monoxime, a GSKβ inhibitor in high fat diet induced cognitive impairment in mice
- (2014) Sorabh Sharma et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Region-specific dysregulation of glycogen synthase kinase-3β and β-catenin in the postmortem brains of subjects with bipolar disorder and schizophrenia
- (2014) Ghanshyam N Pandey et al. BIPOLAR DISORDERS
- Lower phosphorylated glycogen synthase kinase-3B levels in platelets of patients with schizophrenia: increment by olanzapine treatment
- (2014) Aline Siqueira Ferreira et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- GSK3 Alpha and Beta Are New Functionally Relevant Targets of Tivantinib in Lung Cancer Cells
- (2013) Lily L. Remsing Rix et al. ACS Chemical Biology
- Health Outcomes and Cost of Care Among Older Adults with Schizophrenia: A 10-Year Study Using Medical Records Across the Continuum of Care
- (2013) Hugh C. Hendrie et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Association ofGSK-3βGenetic Variation With GSK-3β Expression, Prefrontal Cortical Thickness, Prefrontal Physiology, and Schizophrenia
- (2013) Giuseppe Blasi et al. AMERICAN JOURNAL OF PSYCHIATRY
- Newly developed glycogen synthase kinase-3 (GSK-3) inhibitors protect neuronal cells death in amyloid-beta induced cell model and in a transgenic mouse model of Alzheimer’s disease
- (2013) Min-Young Noh et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Glycogen Synthase Kinase-3 Inhibitors Reverse Deficits in Long-term Potentiation and Cognition in Fragile X Mice
- (2013) Aimee V. Franklin et al. BIOLOGICAL PSYCHIATRY
- Antisense oligonucleotide against GSK-3β in brain of SAMP8 mice improves learning and memory and decreases oxidative stress: Involvement of transcription factor Nrf2 and implications for Alzheimer disease
- (2013) Susan A. Farr et al. FREE RADICAL BIOLOGY AND MEDICINE
- Glycogen synthase kinase-3 inhibition prevents learning deficits in diabetic mice
- (2013) Matthew R. King et al. JOURNAL OF NEUROSCIENCE RESEARCH
- The role of serotonin in cognitive function: evidence from recent studies and implications for understanding depression
- (2013) Philip Cowen et al. JOURNAL OF PSYCHOPHARMACOLOGY
- HIV-associated neurocognitive disorder
- (2013) David B Clifford et al. LANCET INFECTIOUS DISEASES
- GSK-3β Polymorphism Discriminates Bipolar Disorder and Schizophrenia: A Systematic Meta-Analysis
- (2013) Hui Tang et al. MOLECULAR NEUROBIOLOGY
- Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders
- (2013) Breno Diniz et al. Neuropsychiatric Disease and Treatment
- Glycogen Synthase Kinase 3 Inhibition Promotes Adult Hippocampal Neurogenesis in Vitro and in Vivo
- (2012) Jose A. Morales-Garcia et al. ACS Chemical Neuroscience
- Pharmacological approaches in bipolar disorders and the impact on cognition: a critical overview
- (2012) V. V. Dias et al. ACTA PSYCHIATRICA SCANDINAVICA
- Biphasic Dose-Dependent Effect of Lithium Chloride on Survival of Human Hormone-Dependent Breast Cancer Cells (MCF-7)
- (2012) Muralidharan Suganthi et al. BIOLOGICAL TRACE ELEMENT RESEARCH
- Does Lithium Prevent Alzheimerʼs Disease?
- (2012) Orestes V. Forlenza et al. DRUGS & AGING
- Lithium-associated hypercalcemia and hyperparathyroidism in the elderly: What do we know?
- (2012) Susan W. Lehmann et al. JOURNAL OF AFFECTIVE DISORDERS
- Glycogen synthase kinase 3β gene polymorphisms may be associated with bipolar I disorder and the therapeutic response to lithium
- (2012) Yen-Feng Lin et al. JOURNAL OF AFFECTIVE DISORDERS
- Inhibition of Glycogen Synthase Kinase-3 Ameliorates β-Amyloid Pathology and Restores Lysosomal Acidification and Mammalian Target of Rapamycin Activity in the Alzheimer Disease Mouse Model
- (2012) Limor Avrahami et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes
- (2012) Philip T.T. Ly et al. JOURNAL OF CLINICAL INVESTIGATION
- Selectively Silencing GSK-3 Isoforms Reduces Plaques and Tangles in Mouse Models of Alzheimer's Disease
- (2012) D. E. Hurtado et al. JOURNAL OF NEUROSCIENCE
- Lithium Reduces BACE1 Overexpression, Beta Amyloid Accumulation, and Spatial Learning Deficits in Mice with Traumatic Brain Injury
- (2012) Fengshan Yu et al. JOURNAL OF NEUROTRAUMA
- GSK-3 mediates the release of IL-1β, TNF-α and IL-10 from cortical glia
- (2012) Holly F. Green et al. NEUROCHEMISTRY INTERNATIONAL
- Dual inhibitor of PDE7 and GSK-3 – VP1.15 acts as antipsychotic and cognitive enhancer in C57BL/6J mice
- (2012) Tatiana V. Lipina et al. NEUROPHARMACOLOGY
- Lithium Treatment of APPSwDI/NOS2−/− Mice Leads to Reduced Hyperphosphorylated Tau, Increased Amyloid Deposition and Altered Inflammatory Phenotype
- (2012) Tiffany L. Sudduth et al. PLoS One
- The Effects of Glycogen Synthase Kinase-3beta in Serotonin Neurons
- (2012) Wenjun Zhou et al. PLoS One
- Inhibition of glycogen synthase kinase-3 attenuates psychotomimetic effects of ketamine
- (2012) Ming-Huan Chan et al. SCHIZOPHRENIA RESEARCH
- Enhanced Lithium-Induced Brain Recovery Following Cranial Irradiation Is Not Impeded by Inflammation
- (2012) Jordane Malaterre et al. Stem Cells Translational Medicine
- Requirement of adult-born neurons for hippocampus-dependent learning
- (2011) Antonia Marín-Burgin et al. BEHAVIOURAL BRAIN RESEARCH
- Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial
- (2011) Orestes V. Forlenza et al. BRITISH JOURNAL OF PSYCHIATRY
- Functional significance of glycogen synthase kinase-3 regulation by serotonin
- (2011) Abigail M. Polter et al. CELLULAR SIGNALLING
- Inhibition of GSK3 improves hippocampus-dependent learning and rescues neurogenesis in a mouse model of fragile X syndrome
- (2011) W. Guo et al. HUMAN MOLECULAR GENETICS
- Evidence for Irreversible Inhibition of Glycogen Synthase Kinase-3β by Tideglusib
- (2011) Juan Manuel Domínguez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Exploring the Binding Sites of Glycogen Synthase Kinase 3. Identification and Characterization of Allosteric Modulation Cavities
- (2011) Valle Palomo et al. JOURNAL OF MEDICINAL CHEMISTRY
- A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer’s disease
- (2011) Tomohiro Onishi et al. JOURNAL OF NEUROCHEMISTRY
- A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health
- (2011) Jean-Martin Beaulieu JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Glycogen Synthase Kinase-3 Is a Functional Modulator of Serotonin-1B Receptors
- (2011) L. Chen et al. MOLECULAR PHARMACOLOGY
- The effects of neuropsychiatric drugs on glycogen synthase kinase-3 signaling
- (2011) L.P. Sutton et al. NEUROSCIENCE
- Effects of antipsychotic drugs on BDNF, GSK-3β, and β-catenin expression in rats subjected to immobilization stress
- (2011) Sung Woo Park et al. NEUROSCIENCE RESEARCH
- Involvement of the Glycogen Synthase Kinase-3 Signaling Pathway in TBI Pathology and Neurocognitive Outcome
- (2011) Pramod K. Dash et al. PLoS One
- Glycogen Synthase Kinase-3: A Promising Therapeutic Target for Fragile X Syndrome
- (2011) Marjelo A. Mines et al. Frontiers in Molecular Neuroscience
- GSK-3: Functional Insights from Cell Biology and Animal Models
- (2011) Oksana Kaidanovich-Beilin et al. Frontiers in Molecular Neuroscience
- GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS
- (2011) Hagit Eldar-Finkelman et al. Frontiers in Molecular Neuroscience
- Regulation of glycogen synthase kinase-3 during bipolar mania treatment
- (2010) Xiaohong Li et al. BIPOLAR DISORDERS
- Does lithium protect against dementia?
- (2010) Lars Vedel Kessing et al. BIPOLAR DISORDERS
- Neuroprotective effect and cognitive outcome of chronic lithium on traumatic brain injury in mice
- (2010) Zu-Fu Zhu et al. BRAIN RESEARCH BULLETIN
- Temporal lobe grey matter volume in schizophrenia is associated with a genetic polymorphism influencing glycogen synthase kinase 3-β activity
- (2010) F. Benedetti et al. GENES BRAIN AND BEHAVIOR
- Excellent lithium responders have normal cognitive functions and plasma BDNF levels
- (2010) Janusz K. Rybakowski et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Risk factors for cognitive impairment in elderly bipolar patients
- (2010) Sigfried N.T.M. Schouws et al. JOURNAL OF AFFECTIVE DISORDERS
- Lithium Treatment Effects on the Neuropsychological Functioning of Patients With Bipolar I Disorder
- (2010) Carlos López-Jaramillo et al. JOURNAL OF CLINICAL PSYCHIATRY
- Indirubin-3'-monoxime rescues spatial memory deficits and attenuates β-amyloid-associated neuropathology in a mouse model of Alzheimer's disease
- (2010) Yun Ding et al. NEUROBIOLOGY OF DISEASE
- Novel Insights into Lithium’s Mechanism of Action: Neurotrophic and Neuroprotective Effects
- (2010) Jorge A. Quiroz et al. NEUROPSYCHOBIOLOGY
- Is Glycogen Synthase Kinase-3 a Central Modulator in Mood Regulation?
- (2010) Xiaohua Li et al. NEUROPSYCHOPHARMACOLOGY
- Indirubin-3′-oxime inhibits inflammatory activation of rat brain microglia
- (2010) Hoon-Ji Jung et al. NEUROSCIENCE LETTERS
- Lithium Improves Hippocampal Neurogenesis, Neuropathology and Cognitive Functions in APP Mutant Mice
- (2010) Anna Fiorentini et al. PLoS One
- Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of Fragile X syndrome
- (2009) Christopher J. Yuskaitis et al. BIOCHEMICAL PHARMACOLOGY
- Design, synthesis and structure–activity relationships of 1,3,4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3β
- (2009) Morihisa Saitoh et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Identifying and treating cognitive impairment in bipolar disorder
- (2009) Joseph F Goldberg et al. BIPOLAR DISORDERS
- Molecular Pathology of Neuro-AIDS (CNS-HIV)
- (2009) Leslie Crews et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- GSK-3: A key player in neurodegeneration and memory
- (2009) Karl Peter Giese IUBMB LIFE
- Lithium Trial in Alzheimer's Disease
- (2009) Harald Hampel et al. JOURNAL OF CLINICAL PSYCHIATRY
- Effects of Lithium on Cognitive Performance
- (2009) Aliza P. Wingo et al. JOURNAL OF CLINICAL PSYCHIATRY
- 2-{3-[4-(Alkylsulfinyl)phenyl]-1-benzofuran-5-yl}-5-methyl-1,3,4-oxadiazole Derivatives as Novel Inhibitors of Glycogen Synthase Kinase-3β with Good Brain Permeability
- (2009) Morihisa Saitoh et al. JOURNAL OF MEDICINAL CHEMISTRY
- Regulation of Serotonin 1B Receptor by Glycogen Synthase Kinase-3
- (2009) L. Chen et al. MOLECULAR PHARMACOLOGY
- Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1ΔE9 mouse model of Alzheimer's disease
- (2009) E M Toledo et al. MOLECULAR PSYCHIATRY
- Emerging roles of Wnts in the adult nervous system
- (2009) Nibaldo C. Inestrosa et al. NATURE REVIEWS NEUROSCIENCE
- GSK3ß, a centre-staged kinase in neuropsychiatric disorders, modulates long term memory by inhibitory phosphorylation at Serine-9
- (2009) I. Dewachter et al. NEUROBIOLOGY OF DISEASE
- A novel GSK-3β inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo
- (2009) L. Serenó et al. NEUROBIOLOGY OF DISEASE
- Tau-knockout mice show reduced GSK3-induced hippocampal degeneration and learning deficits
- (2009) Elena Gómez de Barreda et al. NEUROBIOLOGY OF DISEASE
- Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain
- (2009) K. Ghosal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lithium treatment in Alzheimer’s disease does not promote cognitive enhancement, but may exert long-term neuroprotective effects
- (2009) Nunzio Pomara PSYCHOPHARMACOLOGY
- Neuropsychological profile in bipolar disorder: a preliminary study of monotherapy lithium-treated euthymic bipolar patients evaluated at a 2-year interval
- (2008) M. Mur et al. ACTA PSYCHIATRICA SCANDINAVICA
- Wnt Signaling in Neural Circuit Assembly
- (2008) Patricia C. Salinas et al. Annual Review of Neuroscience
- Glycogen synthase kinase-3?? heterozygote knockout mice as a model of findings in postmortem schizophrenia brain or as a model of behaviors mimicking lithium action: negative results
- (2008) Yuly Bersudsky et al. BEHAVIOURAL PHARMACOLOGY
- Neuropsychological task performance in bipolar spectrum illness: genetics, alcohol abuse, medication and childhood trauma
- (2008) Jonathan B Savitz et al. BIPOLAR DISORDERS
- Inhibition of Glycogen Synthase Kinase 3 Attenuates Neurocognitive Dysfunction Resulting from Cranial Irradiation
- (2008) D. K. Thotala et al. CANCER RESEARCH
- A feasibility and tolerability study of lithium in Alzheimer's disease
- (2008) Alastair Macdonald et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Open-Label Treatment Trial of Lithium to Target the Underlying Defect in Fragile X Syndrome
- (2008) Elizabeth Berry-Kravis et al. JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS
- Elevated glycogen synthase kinase-3 activity in Fragile X mice: Key metabolic regulator with evidence for treatment potential
- (2008) Wenzhong William Min et al. NEUROPHARMACOLOGY
- GSK-3β Is Required for Memory Reconsolidation in Adult Brain
- (2008) Tetsuya Kimura et al. PLoS One
- Role of GSK3 in behavioral abnormalities induced by serotonin deficiency
- (2008) J.-M. Beaulieu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lithium inhibits proliferation of human esophageal cancer cell line Eca-109 by inducing a G2/M cell cycle arrest
- (2008) Jin-Sheng Wang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- AKT1 Is Associated with Schizophrenia Across Multiple Symptom Dimensions in the Irish Study of High Density Schizophrenia Families
- (2007) Dawn L. Thiselton et al. BIOLOGICAL PSYCHIATRY
- Antidepressant drugs and memory: Insights from animal studies
- (2007) Santiago Monleón et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started